Mr. Jaffé joined Alpha-9 as CFO in May 2021. In the 20 years leading to his current role, he was CFO of several private and public life science companies including LogicBio, Constellation Pharmaceuticals, Zafgen and Alantos Pharmaceuticals. Previously, he was a principal at Earlybird Venture Capital in Munich and a consultant with Boston Consulting Group. Mr. Jaffé holds an MBA from INSEAD (Fontainebleau, France), an MSc in Biology from MIT, and a BS in Chemistry from Universidad Simón Bolivar in his native Venezuela.

• 

  CFO: Chief Financial Officer in Alpha-9 Oncology

  Harnessing the Power of Radiopharmaceuticals